Literature DB >> 2252957

Levels of detection of tumor cells in human bone marrow with or without prior culture.

S S Joshi1, D J Novak, L Messbarger, V Maitreyan, D D Weisenburger, J G Sharp.   

Abstract

With an in vitro culture technique combined with light microscopy, immunocytochemistry and molecular probing, we previously detected occult tumor cells in histologically-normal human bone marrow harvested for autologous transplantation. In this study, we mixed known numbers of malignant lymphoid (Raji and CEM) or breast cancer (MCF-7) cells with normal human bone marrow cells to determine the levels at which tumor cells can be detected before and after culture. Cytocentrifuge preparations were made before culture and after 2 or more weeks of culture and examined by light microscopy. We detected contaminating lymphoma cells at a level of more than 5% before culture, and at a level of 0.01% after culture for 2 or more weeks in 2% human lymphocyte conditioned medium. Before culture, we detected MCF-7 cells at a level of 0.001% using glucose oxidase immunocytochemical staining techniques; these cells were detected at a level of 0.00001% after culture. Since, of necessity, these calibrations rations were performed using cell lines, it is likely that these results overestimate the absolute sensitivity of these methods for detection of tumor cells in patient samples. We found the glucose oxidase immunocytochemical method more specific for detecting occult tumor cells in bone marrow than the immunoperoxidase staining method because of the absence of non-specific staining arising from endogenous peroxidase in bone marrow cells which makes the interpretation of the latter difficult. We conclude that culture techniques can increase the sensitivity of detection of occult tumor cells in human bone marrow about 100-fold.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2252957

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.

Authors:  W A Franklin; E J Shpall; P Archer; C S Johnston; S Garza-Williams; L Hami; M A Bitter; R C Bast; R B Jones
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Detection of bone marrow metastases in neuroblastoma using a short term tissue culture technique.

Authors:  J A Adams; A M Kelsey; T F Carr; R F Stevens; P Morris-Jones
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

3.  Limitations of the use of single base changes in the p53 gene to detect minimal residual disease of breast cancer.

Authors:  R K B Dang; R S Anthony; J I O Craig; R C F Leonard; A C Parker
Journal:  Mol Pathol       Date:  2002-06

4.  Selective growth of freshly isolated human breast epithelial cells cultured at low concentrations in the presence or absence of bone marrow cells.

Authors:  J T Emerman; J Stingl; A Petersen; E J Shpall; C J Eaves
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer.

Authors:  J-Y Pierga; C Bonneton; H Magdelénat; A Vincent-Salomon; C Nos; P Pouillart; J-P Thiery
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.